Related Experiment Videos
Adrenal-sparing surgery for phaeochromocytoma
H P Neumann1, B U Bender, M Reincke
1Department of Nephrology and Hypertension, Albert-Ludwigs-University, Freiburg, Germany.
The British Journal of Surgery
|February 23, 1999
Summary
Adrenal-sparing surgery for phaeochromocytoma is safe and effective, preserving adrenal function in most patients. This technique is particularly beneficial for hereditary phaeochromocytoma cases.
Area of Science:
- Endocrinology
- Surgical Oncology
- Genetics
Background:
- Phaeochromocytoma treatment typically involves adrenalectomy, leading to steroid dependence in patients with bilateral tumors.
- An adrenal-sparing surgical approach was introduced in 1985 to mitigate this complication.
Purpose of the Study:
- To review the outcomes of adrenal-sparing surgery for phaeochromocytoma.
- To assess the safety and efficacy of this technique, particularly in hereditary cases.
Main Methods:
- A review of 39 patients (16 men, 23 women; ages 10-76) treated with adrenal-sparing surgery for phaeochromocytoma since 1985.
- Patients were evaluated biochemically and clinically for recurrence, with some undergoing adrenocorticotrophic hormone stimulation tests.
Main Results:
- Adrenal-sparing surgery was successful in 37 of 39 patients; only one required total adrenalectomy, and another became steroid-dependent due to complications.
- 12 patients with bilateral tumors did not require steroid replacement post-surgery.
- Adrenocortical function was preserved in most patients, and one recurrence was noted in a patient with von Hippel-Lindau disease.
- 26 patients (67%) had hereditary phaeochromocytoma, indicating a high prevalence in the study cohort.
Conclusions:
- Adrenal-sparing surgery is a safe and effective treatment for phaeochromocytoma.
- This approach may become the preferred treatment for patients with hereditary phaeochromocytoma, preserving endocrine function.